Current trends in digestive disorders focus on precision medicine, where treatments are tailored to individual genetic and microbiome profiles for better outcomes. Advancements in non-invasive diagnostic tools, like advanced imaging and biomarkers, are enhancing early detection. Innovations in pharmacology are providing targeted therapies for chronic conditions such as IBD and GERD. Furthermore, the integration of digital health technologies is transforming patient monitoring and management in real-time.
Track 2-1: GI Cancers & Tumor Markers
Track 2-2: IBD & Immunotherapy
Track 2-3: Liver Diseases & Hepatology
Track 2-4: Endoscopic Techniques
Track 2-5: Microbiome & Gut Health
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
